+216 98 414 314
Properties of: Ibrutinib
Formula:
C25H24N6O2
CAS Number:
936563-96-1
Overview
Ibrutinib is a medication used in the treatment of certain types of blood cancers, particularly chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström macroglobulinemia. It is classified as a Bruton's tyrosine kinase (BTK) inhibitor.